Gastroenterology Department, Digestive Endoscopy Unit, Rouen University Hospital, Rouen Cedex, France.
Aliment Pharmacol Ther. 2009 Aug 15;30(4):399-405. doi: 10.1111/j.1365-2036.2009.04051.x. Epub 2009 May 26.
Mallory-Weiss syndrome (MWS) with active bleeding at endoscopy may require endoscopic haemostasis the modalities of which are not well-defined.
To compare the efficacy of endoscopic band ligation vs. hemoclip plus epinephrine (adrenaline) in bleeding MWS.
From 2001 to 2008, 218 consecutive patients with a MWS at endoscopy were hospitalized in our Gastrointestinal Bleeding Unit. In 56 patients (26%), an endoscopic haemostasis was required because of active bleeding. Band ligation was performed in 29 patients (Banding group), while hemoclip application plus epinephrine injection was performed in 27 patients (H&E group). Treatment efficacy and early recurrent bleeding were retrospectively compared between the two groups.
Primary endoscopic haemostasis was achieved in all patients. Recurrent bleeding occurred in 0% in Banding group vs. 18% in H&E group (P = 0.02). The use of hemoclips plus epinephrine (OR = 3; 95% CI = 1.15-15.8) and active bleeding at endoscopy (OR = 1.9; 95% CI = 1.04-5.2) were independent predictive factors of early recurrent bleeding.
Haemostasis by hemoclips plus epinephrine was an independent predictive factor of rebleeding. This result suggests that band ligation could be the first choice endoscopic treatment for bleeding MWS, but requires further prospective assessment.
Mallory-Weiss 综合征(MWS)伴内镜下活动性出血可能需要内镜止血,但止血方式尚未明确。
比较内镜套扎与夹闭联合肾上腺素在 MWS 出血中的疗效。
2001 年至 2008 年,218 例 MWS 患者在我院胃肠出血科住院。56 例(26%)患者因活动性出血需要内镜止血。29 例患者接受套扎治疗(套扎组),27 例患者接受夹闭联合肾上腺素注射治疗(H&E 组)。回顾性比较两组治疗效果和早期再出血情况。
所有患者均达到初次内镜止血。套扎组无再出血(0%),H&E 组再出血率为 18%(P=0.02)。夹闭联合肾上腺素应用(OR=3;95%CI=1.15-15.8)和内镜下活动性出血(OR=1.9;95%CI=1.04-5.2)是早期再出血的独立预测因素。
夹闭联合肾上腺素是再出血的独立预测因素。这一结果表明,套扎可能是治疗 MWS 出血的首选内镜治疗方法,但需要进一步前瞻性评估。